Living Cell Technologies reports promising initial data from DiabeCell phase I/II trial Oct. 10, 2007
Improved lipid profile and insulin sensitivity by MBX-213, a novel dual PPARalpha/gamma agonist Oct. 10, 2007
Akesis seeks FDA approval to commence phase IIa evaluation of AKP-020 for type 2 diabetes Oct. 10, 2007
Novel treatment options for obesity described in recent Servier and Pharmacopeia patents Oct. 8, 2007
RSS